Eblasakimab：Eblasakimab
Eblasakimab
Provide From Google
Eblasakimab Monthly Dosing Shows Potential for Best
https://aslanpharma.com
Eblasakimab is the first biologic in moderate-to-severe atopic dermatitis to demonstrate a competitive efficacy profile with once-monthly ...
Provide From Google
Eblasakimab, a novel IL
https://pubmed.ncbi.nlm.nih.go
Eblasakimab is a first-in-class monoclonal antibody under investigation for the treatment of atopic dermatitis (AD), which targets IL-13Rα1, a subunit of ...
Provide From Google
Eblasakimab
https://www.sciencedirect.com
Eblasakimab is a first-in-class monoclonal antibody under investigation for the treatment of atopic dermatitis (AD), which targets IL-13Rα1, a subunit of ...
Provide From Google
Study of Eblasakimab in Male or Female Moderate
https://clinicaltrials.gov
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab ; ASLAN Investigative Site ...